ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Subscription

Journal of Biomolecular Screening

Abbreviation (ISO):J. BIOMOL. SCREENING
•
Identifier (ISSN):1087-0571(Print)
•
Publisher:SAGE Publications Inc.
Clarivate JCR Index Advisory: Not Indexed in Latest JCR
Clarivate Impact Factor (IF 2024)
N/A
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓

Impact Factor Trend (2023–2025)

Clarivate IF trend for Journal of Biomolecular Screening

WoS Q1
01342.3520232.3202402025
Annual Impact Factor Metric
Current (2025):0
Scopus SJR & Rank
N/A

SCImago Journal Rank citation prestige weighting

Scopus / Elsevier Data
H-Index (2021)
69

69 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessSubscription
1articles/year
0% Gold OA•0% Original Research

Aims & Scope

Advancing the Science of Drug Discovery: SLAS Discovery reports how scientists develop and utilize novel technologies and/or approaches to provide and characterize chemical and biological tools to understand and treat human disease. SLAS Discovery is a peer-reviewed journal that publishes scientific reports that enable and improve target validation, evaluate current drug discovery technologies, provide novel research tools, and incorporate research approaches that enhance depth of knowledge and drug discovery success. SLAS Discovery emphasizes scientific and technical advances in target identification/validation (including chemical probes, RNA silencing, gene editing technologies); biomarker discovery; assay development; virtual, medium- or high-throughput screening (biochemical and biological, biophysical, phenotypic, toxicological, ADME); lead generation/optimization; chemical biology; and informatics (data analysis, image analysis, statistics, bio- and chemo-informatics). Review articles on target biology, new paradigms in drug discovery and advances in drug discovery technologies. SLAS Discovery is of particular interest to those involved in analytical chemistry, applied microbiology, automation, biochemistry, bioengineering, biomedical optics, biotechnology, bioinformatics, cell biology, DNA science and technology, genetics, information technology, medicinal chemistry, molecular biology, natural products chemistry, organic chemistry, pharmacology, spectroscopy, and toxicology.

Topics Covered (Recognized by AI)
Biology73%Chemistry72.5%Biochemistry64.3%Genetics62.2%Medicine47.3%Computer science43.5%Physics41.2%Internal medicine33.3%Gene33.2%Bioinformatics31.3%Computational biology28.5%Organic chemistry28.3%Cell biology26.9%High-throughput screening23.6%Nuclear magnetic resonance21.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

10 year
2025Latest
IF0
Articles / Year—
Total Citations—
2024
IF2.297
Articles / Year—
Total Citations—
2023
IF2.355
Articles / Year—
Total Citations—
2016
IF—
Articles / Year1
Total Citations1
2009
IF—
Articles / Year1
Total Citations0

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
Updating
Minor Category (Specific Field):
Updating
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Biomolecular Screening (abbr: J. BIOMOL. SCREENING, ISSN: 1087-0571) is a peer-reviewed international scholarly journal in the field of Biology, published by SAGE Publications Inc. in United States since 1996. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, an H-index of 69.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 1 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with APC fees are not specified. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Subscription
Publisher
SAGE Publications Inc.
Publication Language
English
Frequency
Quarterly
Founding Year
1996
Indexing & Databases
PubMed
Editorial Address
SAGE PUBLICATIONS INC, 2455 TELLER RD, THOUSAND OAKS, USA, CA, 91320

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 582c7fe2-cced-44c5-9e2c-82f6f6a21462
Database Updated: 2026-10-01